Ilaris (Novartis Pharmaceuticals Corporation)
Welcome to the PulseAid listing for the Ilaris drug offered from Novartis Pharmaceuticals Corporation. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Novartis Pharmaceuticals Corporation |
| NON-PROPRIETARY NAME: | canakinumab |
| SUBSTANCE NAME: | CANAKINUMAB |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 2009-06-18 |
| END MARKETING DATE: | 0000-00-00 |
Ilaris HUMAN PRESCRIPTION DRUG Details:
| Item Description | Ilaris from Novartis Pharmaceuticals Corporation |
| LABELER NAME: | Novartis Pharmaceuticals Corporation |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/mL) |
| START MARKETING DATE: | 2009-06-18 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 0078-0582_bb044a74-7007-446d-931b-0238d62db2fc |
| PRODUCT NDC: | 0078-0582 |
| APPLICATION NUMBER: | BLA125319 |
Other CANAKINUMAB Pharmaceutical Manufacturers / Labelers:
